EUVIMEDEUVIMED entdecken
Crossref

Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis

Achuthan Sourianarayanane iD, Michelle R Salemi iD, Brett S Phinney iD, Arthur J McCullough

PROTEOMICS – Clinical Applications · 2024

DOI: 10.1002/prca.202300236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2024. Verfasst von Achuthan Sourianarayanane und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Biomarkers, Liver, Blood Proteins, Proteomics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biomarkers for metabolic dysfunction‐associated steatohepatitis (MASH) have been considered based on proteomic and lipidomic data from plasma and liver tissue without clinical benefits. This study evaluated proteomics‐based plasma and liver tissue biomarkers collected simultaneously from patients with metabolic dysfunction‐associated steatotic liver disease (MASLD).

Methods

Liver tissue and plasma samples were collected during liver biopsy to diagnose MASLD. Untargeted proteomics was performed on 64 patients.

Results

Twenty plasma proteins were up‐ or downregulated in patients with MASH compared with those without MASH. The potential biomarkers utilizing the best combinations of these plasma proteins had an area under the receiver operating curve (AUROC) of 0.671 for detecting those with MASH compared with those without it. However, none of the 20 plasma proteins were represented among the significantly regulated liver tissue proteins in patients with MASH. Ten of them displayed a trend and relevance in liver tissue with MASLD progression. These 10 plasma proteins had an AUROC of 0.793 for MASH identification and higher positive and negative predictive values.

Conclusion

The plasma and liver protein expressions of patients with MASH were not directly comparable. Plasma protein biomarkers that are also expressed in liver tissue can help improve MASH detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersLiverBlood ProteinsProteomicsFatty LiverHumansMaleFemaleMiddle AgedAdultAged

Stichwörter der Autor:innen

MASHMASLDNAFLDNASHbiomarkernoninvasive testsproteomics

Substanzen

BiomarkersBlood Proteins

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Proteomics Core Facility, UC Davis Genome Center, University of California, Davis, California, USA.
  • Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Achuthan Sourianarayanane, Michelle R Salemi, Brett S Phinney

Förderung

  • NIH HHS

Zitieren

APA

Sourianarayanane, A., Salemi, M. R., Phinney, B. S., & McCullough, A. J. (2024). Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.202300236

Vancouver

Sourianarayanane A, Salemi MR, Phinney BS, McCullough AJ. Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis. PROTEOMICS – Clinical Applications. 2024. doi:10.1002/prca.202300236

BibTeX
@article{Sourianarayanane2024,
  author = {Sourianarayanane, Achuthan and Salemi, Michelle R and Phinney, Brett S and McCullough, Arthur J},
  title = {Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis},
  journal = {PROTEOMICS – Clinical Applications},
  year = {2024},
  doi = {10.1002/prca.202300236}
}
Kostenlos starten →